“merck” Archives

in
Entry Author Date Location
Laing Tapped to Lead New Capital City Innovation District in Austin 07/20/17 Texas
Eyeing Recent FDA Decision, Promega to Seek Approvals for MSI Assay 07/10/17 Wisconsin
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal 07/06/17 New York
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
Portola Pharmaceuticals’ Drug to Prevent Blood Clots Wins FDA Nod 06/23/17 San Francisco
Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More 06/23/17 National
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests? 06/03/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Sema4, Eric Schadt’s Genomics Startup, Spins Out of Sinai to Raise Cash 06/01/17 New York
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment 04/20/17 Texas
A.I. Startup Atomwise Has a Deal for Researchers Hunting for New Drugs 04/19/17 San Francisco
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership 04/11/17 Boston
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Gedeon Richter Gets Ex-U.S. Rights for Evestra Urological Product 04/06/17 Texas
Page 1 of 22 next page »